Neil Woodford
Prothena guts workforce by more than half, after trial failure
May 25, 2018Medical Communications Neil Woodford, Prothena, Roche, biotech, drugs, pharma, pharmaceutical
Prothena Therapeutics has acted drastically by slashing staff numbers by more than half, after the failure of two pivotal trials …
Sir Andrew Witty announces decision to step down as CEO of GSK
March 17, 2016Medical Communications, Research and Development Andrew Witty, GSK, GlaxoSmithKline, Neil Woodford, Sir Andrew Witty, Witty, gsk break up, gsk split, retirement, steps down
Sir Andrew Witty has announced his decision to retire from his role as chief executive officer of pharmaceutical giant, GlaxoSmithKline …
Investment group renews calls for GSK to split
January 8, 2016Medical Communications, Sales and Marketing GSK, Neil Woodford, investment, restructure
Multi-million pound fund manager Neil Woodford has renewed his call for GSK to break up into separate business units, amid …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
August 14, 2026
